8Takebayashi K,Suetsugu M,Wakabayashi S,et al.Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus[J].Metabolism,2007,56:451-458.
9Retnakaran R,Youn B S,Liu Y,et al.Correlation of circulating full-length visfatin (PBEF/NAMPT)with metabolic parameters in subjects with and without diabetes:a cross-sectional study [J].Clin Endocrinol (Oxf), 2008.69:885-893.
10Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus [ J ].J Clin Endoerinol Metab,2006,91:295-299.
5French M C,Littlejohn R P,Greer G J,et al. Growth hormone and ghrelin receptor genes are differentially expressed between genetically lean and fat selection lines of sheep[J]. Journal of Animal Science, 2006, 84(2) :324-331.
6Wertz-Lutz A E, Daniel J A, Clapper J A, et al. Pro- longed, moderate nutrient restriction in beef cattle re- sults in persistently elevated circulating ghrelin con- centrations [J]. Journal of Animal Science, 2007, 86(3) ..564-575.
7Kosteli A, Sugaru E, Haemmerie G, et al. Weight loss and lipolysis promote a dynamic immune response in routine adipose tissue[J]. J Clin Invest, 2010, 120(10) :3466-3479.
8Berger J P, Akiyama T E, Meinke P T. PPARs : Ther- apeutic targets for metabolic disease[J]. Trends Pharmacol Sci, 2005,26 (5) : 244-251.
9Sato K, Fukao K, Seki Y, et al. Expression of the chicken peroxisome proliferator-activated receptor- gamma gene is influenced by aging, nutrition, and ago- nist administration[J]. Poult Sci, 2004, 83(8) : 1342-1347.
